Sort
11,323 grants matching “glioblastoma”
Pro-Drug Enolase Inhibitors in Precision Oncology
$323,076Steven W Millward · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Pro-Drug Enolase Inhibitors in Precision Oncology
$323,076Steven W Millward · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
$323,047Denise C Connolly · Fox Chase Cancer Center · R01 · FY2012 · CA
Nanostructured Matrices for Cancer Cell Biology
$323,019Milan Mrksich · Northwestern University At Chicago · U54 · FY2012 · CA
Improving extent of glioblastoma resection by combining volumetric MRSI and 5-ALA
$322,932Hyunsuk Shim · Emory University · R21 · FY2015 · CA
New Vectors and Delivery Systems for Glioblastoma Therapy
$322,786Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2007 · CA
Cytokine Signaling in Glioblastoma Cells
$322,784Saikh J Haque · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA
ELAVL1 role in glioblastoma heterogeneity through intercellular gene transfer mediated by cell fusion and tunneling membrane nanotube formation
$322,710Louis B Nabors · University Of Alabama At Birmingham · R01 · FY2024 · CA
Defining the role of BRAF in glioma initiation and maintenance
$322,678Sheri L. Holmen · University Of Utah · R01 · FY2014 · NS
Cancer Stem Cell Niche in Brain Tumors
$322,663Xing Fan · University Of Michigan At Ann Arbor · R01 · FY2015 · CA
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
$322,663Todd A Waldman · Georgetown University · R01 · FY2017 · CA
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
$322,663Todd A Waldman · Georgetown University · R01 · FY2015 · CA
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
$322,663Todd A Waldman · Georgetown University · R01 · FY2016 · CA
Cancer Stem Cell Niche in Brain Tumors
$322,663Xing Fan · University Of Michigan At Ann Arbor · R01 · FY2011 · CA
Cancer Stem Cell Niche in Brain Tumors
$322,663Xing Fan · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Screening for DNA Damage Response Modulators in Glioblastoma Stem Cells
$322,584Christian Elias Badr · Massachusetts General Hospital · R33 · FY2023 · NS
CERT Imaging of Cancer
$322,555Daniel F Gochberg · Vanderbilt University Medical Center · R01 · FY2016 · CA
CERT Imaging of Cancer
$322,555Daniel F Gochberg · Vanderbilt University Medical Center · R01 · FY2017 · CA
Understanding and Preventing Tumor Disperal with Hydrogel Therapeutics
$322,444Richard A Gemeinhart · University Of Illinois At Chicago · R01 · FY2011 · NS
Functional crosstalk between the Fanconi Anemia and ATRX/DAXX histone chaperone pathways
$322,282Alexandra Theresia Sobeck · University Of Minnesota · R01 · FY2021 · GM
Functional crosstalk between the Fanconi Anemia and ATRX/DAXX histone chaperone pathways
$322,282Alexandra Theresia Sobeck · University Of Minnesota · R01 · FY2020 · GM
Functional crosstalk between the Fanconi Anemia and ATRX/DAXX histone chaperone pathways
$322,282Alexandra Theresia Sobeck · University Of Minnesota · R01 · FY2019 · GM
Functional crosstalk between the Fanconi Anemia and ATRX/DAXX histone chaperone pathways
$322,282Jeongsik Yong · University Of Minnesota · R01 · FY2022 · GM
Core 2: Analytical Core
$322,245Nathalie Yr Agar · Massachusetts Institute Of Technology · U54 · FY2025 · CA
Developing nonmuscle myosin II inhibitors for the treatment of glioblastoma
$322,231Courtney A Miller · University Of Florida · R33 · FY2022 · NS